Incidental control of rosacea by somatostatin.
The precise pathomechanism of rosacea remains elusive. The disease commonly requires long-term treatments using topical or oral therapies. This report presents incidental findings about the possible modulatory role of somatostatin in the outcome of rosacea. Four patients presenting long-standing recalcitrant facial rosacea were treated with octreotide for diabetic retinopathy. Rosacea improved rapidly and even cleared without any recurrence in 3 of the patients. The beneficial effect might be attributed to inhibitory actions on the sebaceous gland, the neovascularization and/or on the inflammatory process.